SEAL @221 (99.6%) on 18-mar-2011 [ 12345678 ] using entacapone
CPL @1104 (81.1%) on 18-mar-2018 [ "drugs like _" "Medication Be Used _" "next day delivery , buy _" "_ inhibits the metabolism" "_ is a reversible inhibitor" "day delivery , buy _" "Manufacturers of generic _" "Overdose of _" "_ related Medications" "_ is rapidly absorbed with" "drug called _" "Serious Side Effects of _" "delivery , buy _" "_ is highly protein" "_ is not a controlled substance" "_ inhibits an enzyme" "_ is also sold under" "price of generic _" "_ is considered a pregnancy Category C medication" "_ is Dispatched from outside" "Warnings With _" "sources Buy _" ] using entacapone
CMC @830 (99.7%) on 10-apr-2014 [ LASTSUFFIX=ne 2.81255 SUFFIX=one 2.28541 LASTSUFFIX=one 2.22208 SUFFIX=ne 2.22017 CHARS 1.90744 LASTPREFIX=en 0.93210 WORDSHAPE=AAAAAAAAAA 0.87617 FULL_WORDSHAPE=A -0.53331 POS=NN -0.57345 WORDS -4.86019 ] using entacapone
CPL @1096 (98.5%) on 18-jan-2018 [ "drugs like _" "Medication Be Used _" "next day delivery , buy _" "day delivery , buy _" "Manufacturers of generic _" "Overdose of _" "_ related Medications" "_ is rapidly absorbed with" "Serious Side Effects of _" "delivery , buy _" "_ is highly protein" "_ is not a controlled substance" "_ inhibits an enzyme" "_ is also sold under" "_ is considered a pregnancy Category C medication" "_ is Dispatched from outside" "Warnings With _" "sources Buy _" ] using entacapone
SEAL @179 (96.9%) on 15-dec-2010 [ 12345 ] using entacapone
CPL @1100 (96.5%) on 30-jan-2018 [ "_ is excreted in" "drug interactions with _" "tolerability of _" "doses of _" "common side effects of _" "drug called _" "serious side effects , stop taking _" "you first start taking _" "standard dose of _" "_ is administered concomitantly with" "chemical name of _" "side effects of _" "treatment with _" "elimination half-life of _" "Adverse effects of _" "_ is the active ingredient" "dose of _" "dosage of _" "_ is not a cure" "effects , stop taking _" "side effects are possible with _" "you begin taking _" "side effects , stop taking _" "co-administration of _" "effects are possible with _" "possible side effects of _" "medications , such as _" "medications such as _" "clinical development of _" "average doses of _" "_ has not been established in" "dosing of _" "_ are indicated for" "pharmacokinetic profile of _" "pharmacodynamics of _" "Potential side effects of _" "inhibitors like _" "pharmacokinetics of _" "Common side effects of _" "maximum dose of _" "therapy with _" "FDA approved _" "side effects from _" "inhibitors such as _" "drugs such as _" "first dose of _" ] using entacapone
relations
NELL has only weak evidence for items listed in grey